Gary Levine, MD, President of National Consortium of Breast Centers, to Lead MemorialCare Health System Breast Centers in Southern California


Get Permission

Gary Levine, MD

Gary Levine, MD, a breast radiologist, is joining MemorialCare Health System as Medical Director of MemorialCare Breast Centers in Orange and Los Angeles counties. Dr. Levine, President of the National Consortium of Breast Centers, will partner with physician leadership teams at MemorialCare hospitals, including breast surgeons, medical oncologists, radiation oncologists, diagnostic radiologists, pathologists, genetic counselors, certified breast patient navigators, and other clinicians that work together in interdisciplinary teams to prevent, detect, and treat breast cancer. Dr. Levine has more than 20 years of experience in breast imaging and breast center leadership, including 10 years as Medical Director of Breast Imaging for Hoag Breast Care Center.

Dr. Levine serves as an Associate Clinic Professor of Radiology at the University of Southern California School of Medicine and as an Assistant Clinical Professor in the Department of Radiological Services at University of California Irvine.

“The addition of a renowned and highly regarded breast radiologist with Dr. Levine’s experience, expertise, and national reputation furthers MemorialCare’s leadership as among the top centers for breast health and breast cancer,” says Barry Arbuckle, PhD, President and CEO of MemorialCare Health System.

Dr. Levine is considered a pioneer in the technique of breast tumor cryoablation, a procedure that involves freezing breast tumors, and assisted by ultrasound guidance, removing those tumors with a minimally invasive procedure.

“I’m thrilled to be joining the caring and compassionate physicians and staff of MemorialCare Breast Centers,” said Dr. Levine. “I look forward to partnering with these remarkable professionals in advancing breast health and ensuring the continuance of the highest quality of care and access to the latest research and clinical trials for those facing breast cancer and their families.” ■

 

 



Advertisement

Advertisement



Advertisement